Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction

被引:51
作者
Gibson, CM
Murphy, SA
Morrow, DA
Aroesty, JM
Gibbons, RJ
Gourlay, SG
Barron, HV
Giugliano, RP
Antman, EM
Braunwald, E
机构
[1] Brigham & Womens Hosp, Dept Med, TIMI Study Grp, Boston, MA 02115 USA
[2] Mayo Clin, Div Cardiovasc, Rochester, MN USA
[3] Univ Calif San Francisco, Div Cardiovasc, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.ahj.2003.12.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Both epicardial and myocardial perfusion have been associated with clinical outcomes in the setting of ST elevation myocardial infarction (STEMI), and the performance of adjunctive/rescue percutaneous coronary intervention (PCI) may further improve clinical outcomes after fibrinolytic administration. Methods The goal was to develop a simple, broadly applicable angiographic metric that takes into account indices of epicardial and myocardial perfusion both before and after PCI to arrive at a single perfusion grade in patients undergoing cardiac catheterization after fibrinolysis. The angiographic perfusion score (APS) is the sum of the Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG; 0-3) added to the TIMI myocardial perfusion grade (TMPG; 0-3) before and after PCI (total possible grade, 0-12). Failed perfusion was defined as an APS of 0 to 3, partial perfusion was defined as an APS of 4 to 9, and full perfusion was defined as an APS of 10 to 12. The APS was evaluated in patients from the Double-blind, Placebo-contolled, Multicenter Angiographic Trial of Rhumab CD18 in Acute Myocardial Infarction (LIMIT-AMI; n = 394) and Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction-Thrombolysis In Myocardial Infarction (ENTIRE-TIMI) 23 trials (n = 483), and infarct size (120-216 hours after AMI SPECT Technetium-99m Sestamibi data) was assessed in the LIMIT-AMI trial. Results The APS was associated with the incidence of death or myocardial infarction (failed, 16.7% [n = 18]; partial, 2.5% [n = 155]; full, 2.4% [n = 82]; P=.039 for trend) and larger SPECT infarct sizes (failed, median 39% [n = 10]; partial, 12% [n = 79]; and full, 8% [n 35]; P =.002). No patient with full APS died, whereas the mortality rate was 11.1% in patients with a failed APS (P=.03). Conclusions The APS combines grades of epicardial and tissue level perfusion before and after PCI or at the end of diagnostic cardiac catheterization to arrive at a single angiographic variable that is associated with infarct size and the rates of 30-day death or MI. Partial or full angiographic perfusion scores are associated with a halving of infarct size, and no patients with full angiographic perfusion died.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 23 条
  • [1] TIMI PERFUSION GRADE-3 BUT NOT GRADE-2 RESULTS IN IMPROVED OUTCOME AFTER THROMBOLYSIS FOR MYOCARDIAL-INFARCTION - VENTRICULOGRAPHIC, ENZYMATIC, AND ELECTROCARDIOGRAPHIC EVIDENCE FROM THE TEAM-3 STUDY
    ANDERSON, JL
    KARAGOUNIS, LA
    BECKER, LC
    SORENSEN, SG
    MENLOVE, RL
    [J]. CIRCULATION, 1993, 87 (06) : 1829 - 1839
  • [2] Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction - Results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial
    Antman, EM
    Louwerenburg, HW
    Baars, HF
    Wesdorp, JCL
    Hamer, B
    Bassand, JP
    Bigonzi, F
    Pisapia, G
    Gibson, CM
    Heidbuchel, H
    Braunwald, E
    Van de Werf, F
    [J]. CIRCULATION, 2002, 105 (14) : 1642 - 1649
  • [3] Double-blind, randomized trial of an Anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction - Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study
    Baran, KW
    Nguyen, M
    McKendall, GR
    Lambrew, CT
    Dykstra, G
    Palmeri, ST
    Gibbons, RJ
    Borzak, S
    Sobel, BE
    Gourlay, SG
    Rundle, AC
    Gibson, CM
    Barron, HV
    [J]. CIRCULATION, 2001, 104 (23) : 2778 - 2783
  • [4] RESIDUAL FLOW TO THE INFARCT ZONE AS A DETERMINANT OF INFARCT SIZE AFTER DIRECT ANGIOPLASTY
    CLEMENTS, IP
    CHRISTIAN, TF
    HIGANO, ST
    GIBBONS, RJ
    GERSH, BJ
    [J]. CIRCULATION, 1993, 88 (04) : 1527 - 1533
  • [5] Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis
    Dibra, A
    Mehilli, J
    Dirschinger, J
    Pache, J
    Neverve, J
    Schwaiger, M
    Schömig, A
    Kastrati, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 925 - 929
  • [6] RANDOMIZED COMPARISON OF RESCUE ANGIOPLASTY WITH CONSERVATIVE MANAGEMENT OF PATIENTS WITH EARLY FAILURE OF THROMBOLYSIS FOR ACUTE ANTERIOR MYOCARDIAL-INFARCTION
    ELLIS, SG
    DASILVA, ER
    HEYNDRICKX, G
    TALLEY, JD
    CERNIGLIARO, C
    STEG, G
    SPAULDING, C
    NOBUYOSHI, M
    ERBEL, R
    VASSANELLI, C
    TOPOL, EJ
    [J]. CIRCULATION, 1994, 90 (05) : 2280 - 2284
  • [7] Infarct size measured by single photon emission computed tomographic imaging with 99mTc-sestamibi -: A measure of the efficacy of therapy in acute myocardial infarction
    Gibbons, RJ
    Miller, TD
    Christian, TF
    [J]. CIRCULATION, 2000, 101 (01) : 101 - 108
  • [8] Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
    Gibson, CM
    Cannon, CP
    Murphy, SA
    Ryan, KA
    Mesley, R
    Marble, SJ
    McCabe, CH
    Van de Werf, F
    Braunwald, E
    [J]. CIRCULATION, 2000, 101 (02) : 125 - 130
  • [9] TIMI frame count: A quantitative method of assessing coronary artery flow
    Gibson, CM
    Cannon, CP
    Daley, WL
    Dodge, JT
    Alexander, B
    Marble, SJ
    McCabe, CH
    Raymond, L
    Fortin, T
    Poole, WK
    Braunwald, E
    [J]. CIRCULATION, 1996, 93 (05) : 879 - 888
  • [10] Relationship between TIMI frame count and clinical outcomes after thrombolytic administration
    Gibson, CM
    Murphy, SA
    Rizzo, MJ
    Ryan, KA
    Marble, SJ
    McCabe, CH
    Cannon, CP
    Van de Werf, F
    Braunwald, E
    [J]. CIRCULATION, 1999, 99 (15) : 1945 - 1950